Serum Calprotectin – a NET Product – as a Biomarker of Disease Activity in Patients with Systemic Lupus Erythematosus: A Single-Center Case-Control Study from Poland

13 July 2022 : Clinical Research

Iwona Homa-Mlak^1ACDEF*, Marcin Mazurek^1BCEF, Aleksandra Majdan

^1DEF, Radosław Mlak^1ACDE, Maria Majdan

^2ADEF, Teresa Mełecka-Massalska^1ADEF

DOI: 10.12659/MSM.936534

Med Sci Monit 2022; 28:e936534

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 A scatter plot showing the correlation between complement component 3 (C3) (mg/dl) and calprotectin concentration (ng/ml).

Back to the Article